Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
-1.72%
)
Bitcoin
70,436.31
(
-0.11%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: stockbettor post# 123635

Thursday, 07/21/2011 3:34:58 AM

Thursday, July 21, 2011 3:34:58 AM

Post# of 257268
No need to apologize. Amgen has several unexpired G-CSF PEGylation patents in the US 5,824,778, US 5,824,784 (the one you've found), US 6,166,183. From a quick look i suspect they only cover PEGylation when PEG molecule is attached to any amino acid via a carboxyl group at the N-terminus of the protein. Ratiopharm uses a different PEGylation method. See also #msg-65405618
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today